Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Nov 04, 2024$47.07
P/E Ratio
N/A
Market Cap
$3.05B
Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.
Overview
Trading Information
Company